AMCR Institute Launches New Type 2 Diabetes Study

ESCONDIDO, Calif. - April 19, 2013 - PRLog -- AMCR Institute (https://www.amcrinstitute.com/) is conducting a research study using a new investigational medication to treat people with type 2 diabetes who are currently using long-acting insulin.

         Dr. Timothy Bailey, MD, the Institute’s director, said, “We are seeking patients who are currently on medication to treat their type 2 diabetes and who want to try a newly developed medicine that may improve the quality of their treatment and the quality of their life.”

         Participants must be at least 18 years old and using long-acting insulin to treat their type 2 diabetes.  Qualified volunteers will receive all study-related medications, physical examinations, laboratory tests and electrocardiograms at no cost, and may be compensated for their time and travel.

         For more information or to volunteer for this study, contact AMCR Institute at 1-877-567-2627.

         With clinics in Escondido and Temecula, California, AMCR Institute is a clinical research center engaged in trials in the fields of endocrinology and metabolism, focusing on type 1 and type 2 diabetes, lipids, and men’s and women’s health issues, including menopause, osteoporosis, obesity and thyroid disease.  For information call 1-877-567-2627 or visit www.amcrinstitute.com.